STRS Ohio’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $263K | Sell |
1,393
-2
| -0.1% | -$350 | ﹤0.01% | 1368 |
|
|
2025
Q4 | $237K | Buy |
1,395
+2
| +0.1% | +$307 | ﹤0.01% | 1447 |
|
|
2025
Q3 | $184K | Sell |
1,393
-14,393
| -91% | -$1.73M | ﹤0.01% | 1581 |
|
|
2025
Q2 | $1.68M | Sell |
15,786
-659
| -4% | -$71.6K | 0.01% | 740 |
|
|
2025
Q1 | $2.04M | Buy |
+16,445
| New | +$2.15M | 0.01% | 600 |
|
|
2024
Q1 | – | Sell |
-15,082
| Closed | -$1.85M | – | 1982 |
|
|
2023
Q4 | $1.85M | Buy |
15,082
+963
| +7% | +$120K | 0.01% | 639 |
|
|
2023
Q3 | $1.83M | Buy |
14,119
+593
| +4% | +$79K | 0.01% | 634 |
|
|
2023
Q2 | $1.68M | Buy |
13,526
+1,571
| +13% | +$211K | 0.01% | 700 |
|
|
2023
Q1 | $1.75M | Sell |
11,955
-1,294
| -10% | -$191K | 0.01% | 683 |
|
|
2022
Q4 | $2.11M | Sell |
13,249
-594
| -4% | -$87.1K | 0.01% | 606 |
|
|
2022
Q3 | $1.84M | Buy |
13,843
+3,129
| +29% | +$476K | 0.01% | 614 |
|
|
2022
Q2 | $1.67M | Buy |
+10,714
| New | +$1.65M | 0.01% | 672 |
|
|
2021
Q3 | – | Sell |
-14,603
| Closed | -$2.59M | – | 2280 |
|
|
2021
Q2 | $2.59M | Buy |
14,603
+413
| +3% | +$71.5K | 0.01% | 650 |
|
|
2021
Q1 | $2.33M | Buy |
14,190
+563
| +4% | +$92.6K | 0.01% | 652 |
|
|
2020
Q4 | $2.25M | Buy |
13,627
+605
| +5% | +$90.1K | 0.01% | 659 |
|
|
2020
Q3 | $1.86M | Sell |
13,022
-494
| -4% | -$61.2K | 0.01% | 665 |
|
|
2020
Q2 | $1.49M | Buy |
13,516
+6,909
| +105% | +$764K | 0.01% | 718 |
|
|
2020
Q1 | $658K | Buy |
6,607
+726
| +12% | +$93.9K | ﹤0.01% | 929 |
|
|
2019
Q4 | $877K | Buy |
+5,881
| New | +$800K | ﹤0.01% | 1008 |
|
|
2019
Q1 | – | Sell |
-176,422
| Closed | -$21.9M | – | 2076 |
|
|
2018
Q4 | $21.9M | Sell |
176,422
-17,258
| -9% | -$2.56M | 0.11% | 240 |
|
|
2018
Q3 | $32.6M | Sell |
193,680
-23,305
| -11% | -$4.01M | 0.14% | 194 |
|
|
2018
Q2 | $37.4M | Sell |
216,985
-2,239
| -1% | -$366K | 0.16% | 179 |
|
|
2018
Q1 | $33.1M | Sell |
219,224
-4,380
| -2% | -$643K | 0.15% | 192 |
|
|
2017
Q4 | $30.1M | Sell |
223,604
-27,196
| -11% | -$3.77M | 0.13% | 204 |
|
|
2017
Q3 | $36.7M | Buy |
250,800
+15,000
| +6% | +$2.27M | 0.16% | 185 |
|
|
2017
Q2 | $36.7M | Buy |
235,800
+23,900
| +11% | +$3.65M | 0.16% | 181 |
|
|
2017
Q1 | $30.8M | Hold |
211,900
| – | – | 0.13% | 209 |
|
|
2016
Q4 | $23.1M | Sell |
211,900
-3,260
| -2% | -$363K | 0.1% | 251 |
|
|
2016
Q3 | $26.1M | Buy |
215,160
+37,392
| +21% | +$5.04M | 0.12% | 227 |
|
|
2016
Q2 | $25.1M | Buy |
177,768
+16,078
| +10% | +$2.37M | 0.11% | 236 |
|
|
2016
Q1 | $21.1M | Buy |
161,690
+8,594
| +6% | +$1.07M | 0.09% | 253 |
|
|
2015
Q4 | $21.5M | Sell |
153,096
-1,445
| -0.9% | -$200K | 0.1% | 257 |
|
|
2015
Q3 | $20.5M | Buy |
154,541
+20,066
| +15% | +$3.46M | 0.1% | 261 |
|
|
2015
Q2 | $23.7M | Buy |
134,475
+25,757
| +24% | +$4.63M | 0.1% | 262 |
|
|
2015
Q1 | $18.8M | Buy |
108,718
+23,718
| +28% | +$4.07M | 0.08% | 304 |
|
|
2014
Q4 | $13.9M | Hold |
85,000
| – | – | 0.06% | 346 |
|
|
2014
Q3 | $13.6M | Buy |
85,000
+15,000
| +21% | +$2.31M | 0.06% | 350 |
|
|
2014
Q2 | $10.3M | Hold |
70,000
| – | – | 0.05% | 396 |
|
|
2014
Q1 | $9.71M | Buy |
+70,000
| New | +$10.5M | 0.04% | 406 |
|
Other funds holding JAZZ
VPM
VCM
EC
STRS Ohio's JAZZ Position: Q1 2026 in Review
STRS Ohio reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.14% in Q1 2026, selling an estimated $350 and leaving 1,393 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #1368.
STRS Ohio first reported a position in JAZZ in Q1 2014 and has held it in 39 quarters since. The position peaked at $37.4M in Q2 2018. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- STRS Ohio held 1,393 shares of Jazz Pharmaceuticals worth $263K as of Q1 2026.
- STRS Ohio sold 2 Jazz Pharmaceuticals shares in Q1 2026, an estimated $350.
- Jazz Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1368 holding.
- STRS Ohio first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 39 quarters since.
- STRS Ohio's Jazz Pharmaceuticals position peaked at $37.4M in Q2 2018.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.